| Objective: To investigate the clinical efficacy of response elaboration training (RET) combined with repetitive transcranial magnetic stimulation (rTMS) in the treatment of non-fluent aphasia after stroke. Methods: A total of 90 patients with non-fluent aphasia after stroke admitted to the Rehabilitation Department of our hospital from June, 2018 to December, 2020 were randomly divided into control group and combined group. The control group was given conventional language training and low frequency rTMS treatment. On the basis of the treatment of the control group, the combined group was given RET, and the course of treatment was 4 weeks. Before and after treatment, the scores of Western Aphasia Battery (WAB), Chinese Standard Aphasia Examination tool (CRRCAE) action description score, picture description score and daily life Communication Ability Scale (CADL) were compared between the two groups, and the Boston aphasia diagnostic test (BDAE) grading before and after treatment was compared between the two groups. Results: After treatment, the scores of speech, listening comprehension, retelling, naming and AQ in the two groups increased (P<0.01); the CRRCAE scores of action description, picture description and CADL score in the two groups increased (P<0.01); and the grades of BDAE in the two groups had significant improvement (P<0.01). The scores of speech, listening comprehension, retelling, naming and AQ in the combined group after treatment were higher than those in the control group (P<0.01); the CRRCAE scores of action description, picture description and CADL score in the combined group were higher than those in the control group (P<0.01), and the grades of BDAE in the combined group were better than those in the control group (P<0.05). The differences were statistically significant. Conclusion: The rTMS is an effective rehabilitation treatment for non-fluent aphasia. The RET combined with rTMS can increase the WAB score, RRCAE action description score, picture description score and CADL score, improve the BDAE grade, and it has a significant efficacy in the treatment of non-fluent aphasia after stroke. |
